Trial of Idelalisib in Patients With Relapsed Diffuse Large B-cell Lymphoma
Clinical trial NCT03576443 · COMPLETED
Trial details
- NCT number
- NCT03576443
- Sponsor
- Nordic Lymphoma Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-07
- Primary completion
- 2021-09-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.